Clinical Trials Browser

Phase 2 × Androgen Receptor Antagonists × Clear all

NCT03899467 2024-02-12

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Phase 2 Completed

61 enrolled 12 charts

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT00103376 2018-11-05

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Phase 2 Terminated

23 enrolled 9 charts

Prostatic Neoplasms